Purchase Order 75F40124P00175
Award Date
8/27/24
Potential Completion Date
1/24/25
Potential Value
$49K
Federal Agency
Food and Drug Administration
Awardee
BDG Synthesis 2014 LIMITED
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Zealand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $134,500 firm fixed price purchase order to Xenobiotic Laboratories Inc. Biotesting Division for assessment of inhibition activity and substrate potential of two test articles for major human drug transporters. The solicitation requested the prime contractor evaluate Mitragynine and its metabolite 7-hydroxymitragynine to support drug development, using study...
This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $137,935 cost-no-fee delivery order to the University of Mississippi under its PRODUCTION OF CANNABIS AND RELATED MATERIALS FOR RESEARCH program. The one-month order, issued March 23, 2023, tasks the prime contractor with production of cannabis and related materials to support research efforts. Work will be performed in University, Mississippi, and concludes April 22, 2023. No set...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $109,392.00 contract is for compound testing services, including plasma protein binding studies, PXR and AhR activation studies, and CYP inhibition assays on various small molecule compounds. This work supports NIDA's mission to seek fundamental...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a delivery order awarded by the National Institute on Drug Abuse (part of the National Institutes of Health under the Department of Health and Human Services) to Bachem Americas, Inc., a foreign-owned for-profit manufacturer of pharmaceutical ingredients. The $1,050,039.90 firm fixed-price contract is for the manufacture of 200 grams of current Good Manufacturing Practice (cGMP) parathyroid hormone-related protein (PTH-rP). The work is being conducted under the parent "CRO Support...
This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform "Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA)." This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample...